Company Filing History:

21 out of 576

Incyte Pharmaceuticals, Inc.

Years Active: 1997-2007

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7195926 - Antibodies to a cathepsin C homolog (2007-03-27),

2. 6197519 - Pancreas-derived serpin (2001-03-06),

3. 6066488 - Cathepsin C homolog (2000-05-23),

4. 6033848 - Human ice homolog (2000-03-07),

5. 6030791 - Antibody for a homolog of rat elastase IV derived from human pancreas (2000-02-29),

6. 6013448 - Pancreas-derived serpin (2000-01-11),

7. 6007997 - Human cysteine protease (1999-12-28),

8. 6001632 - Human protein disulfide isomerase (1999-12-14),

9. 5955284 - Assay method to detect serpin derived from human hypothalamus (1999-09-21),

10. 5929210 - Serpin derived from human hypothalmus (1999-07-27),

11. 5869637 - Human Kallikrein (1999-02-09),

12. 5856109 - Homolog of rat elastase IV derived from human pancreas (1999-01-05),

13. 5840562 - DNA encoding human cysteine protease (1998-11-24),

14. 5808001 - Human ice homolog antibodies and compositions thereof (1998-09-15),

15. 5804376 - Pancreas-derived serpin (1998-09-08),

Title: Scott Michael Braxton: Innovator in Biotechnology

Introduction

Scott Michael Braxton, based in San Mateo, California, is a prominent inventor with a remarkable portfolio consisting of 22 patents. His work primarily focuses on innovative biotechnological solutions, addressing significant medical challenges through genetic and protein research.

Latest Patents

Among his latest innovations, Scott has contributed to the field with two notable patents. The first is related to "Antibodies to a cathepsin C homolog," which includes nucleotide and amino acid sequences that identify and encode a new cathepsin C homolog (RCP) expressed in THP-1 cells. This invention provides crucial tools such as antisense molecules, expression vectors for the production of purified RCP, and antibodies capable of binding specifically to RCP. Additionally, it encompasses methods for diagnostic tests based on RCP-encoding nucleic acid molecules.

The second patent, "Pancreas-derived serpin," presents novel nucleotide and amino acid sequences encoding a pancreas-derived serpin (PDS) expressed in the human pancreas. This innovative approach also involves antisense molecules, expression vectors, and specific antibodies. Moreover, it provides frameworks for diagnostic tests and a pharmaceutical composition featuring PDS, facilitating crucial medical advancements.

Career Highlights

Scott Michael Braxton has had an impressive career, working at reputable companies such as Incyte Pharmaceuticals, Inc. and Incyte Corporation. His impactful contributions during his tenure at these organizations have established him as a leading figure in the biotech innovation landscape.

Collaborations

Throughout his career, Scott has collaborated with talented professionals like Dinh Diep and Angelo M Delegeane. These collaborations have played a pivotal role in advancing his research and development endeavors.

Conclusion

In summary, Scott Michael Braxton's contributions to biotechnology through his patents and collaborations underscore his commitment to innovation. His work continues to inspire advancements in medical science, showcasing the critical role of inventors in shaping the future of healthcare technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.